Alfred Sandrock is Chief Executive Officer, President, and Director of Voyager Therapeutics, Inc. (VYGR). The company reported total compensation of $2,508,370 for fiscal year 2025.
| Salary | $674,903 |
|---|---|
| Bonus | $0 |
| Stock awards | $611,900 |
| Option awards | $843,900 |
| Non-equity incentive plan | $361,917 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $15,750 |
| Total | $2,508,370 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Voyager Therapeutics, Inc. filed April 28, 2026, accession 0001104659-26-050297.
| Peer-group chief executive median | $3,865,962 |
|---|---|
| Difference from that median | $-1,357,592 |
| Percentile within the disclosed peer group | 33rd |
| Peers with a disclosed figure | 6 |
Medians and percentiles are computed across the peer group Voyager Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Alfred Sandrock this page | Chief Executive Officer, President, and Director | $2,508,370 |
| Jacquelyn Fahey Sandell | Former Chief Legal Officer | $1,474,986 |
| Robin Swartz | Chief Business Officer & Chief Operating Officer | $1,454,300 |
| Toby Ferguson | Former Chief Medical Officer | $1,364,420 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Voyager Therapeutics, Inc. compensation brief.
Alfred Sandrock's compensation sits inside Voyager Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.